Clayton Robertson
Investor Relations Contact presso IMMUNOCORE HOLDINGS PLC
Profilo
Clayton Robertson is currently the Head-Investor Relations at Immunocore Holdings Plc.
Previously, he worked as the Director-Investor Relations at Actinium Pharmaceuticals, Inc. from 2020 to 2021, Director-Investor Relations at PureTech Health Plc in 2020, and Investor Relations Contact at Achillion Pharmaceuticals, Inc. from 2019 to 2020.
He also worked as an Analyst at Trout Capital LLC.
Mr. Robertson completed his undergraduate degree at the University of Pennsylvania.
Posizioni attive di Clayton Robertson
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Investor Relations Contact | 01/02/2021 |
Precedenti posizioni note di Clayton Robertson
| Società | Posizione | Fine |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Investor Relations Contact | 01/02/2021 |
| PURETECH HEALTH PLC | Investor Relations Contact | 01/08/2020 |
| ACHILLION PHARMACEUTICALS, INC. | Investor Relations Contact | 01/05/2020 |
Trout Capital LLC
 Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Analyst-Equity | - |
Formazione di Clayton Robertson
| University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| PURETECH HEALTH PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco. | Finance |
- Borsa valori
- Insiders
- Clayton Robertson
